Feladilimab (Anti-ICOS / CD278)
Feladilimab (Anti-ICOS/CD278) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has potential for its use in cancer research. MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2462 |
Sku # | A2462-1mg*25 |
Pricing | 1mg*25, $2370.00 |